https://www.dovepress.com/feed/journal/121New articles released by Dove Press for Psoriasis: Targets and Therapyen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press Psoriasis: Targets and Therapyhttps://www.dovepress.com/feed/journal/121https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140https://www.dovepress.com/patient-reported-well-being-in-value-based-routine-care-in-psoriatic-d-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyTue, 12 May 2026 19:10:00 +1200https://doi.org/10.2147/PTT.S590189https://www.dovepress.com/genetic-evidence-linking-immune-cell-subsets-to-psoriatic-arthritis-su-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyThu, 16 Apr 2026 04:45:00 +1200https://doi.org/10.2147/PTT.S589733https://www.dovepress.com/core-differentially-expressed-genes-in-psoriasis-lesions-an-integrated-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyFri, 03 Apr 2026 03:05:00 +1300https://doi.org/10.2147/PTT.S580680https://www.dovepress.com/application-of-trichoscopy-and-novel-non-invasive-imaging-techniques-i-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyMon, 30 Mar 2026 20:10:00 +1300https://doi.org/10.2147/PTT.S549372https://www.dovepress.com/indole-3-lactic-acid-attenuates-imq-induced-psoriasiform-dermatitis-in-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyFri, 27 Mar 2026 00:00:00 +1300https://doi.org/10.2147/PTT.S585731https://www.dovepress.com/the-psoriatic-disease-assessment-index-psodai-score-to-evaluate-system-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyMon, 16 Feb 2026 23:55:00 +1300https://doi.org/10.2147/PTT.S548700https://www.dovepress.com/persistence-and-long-term-disease-control-of-interleukin-17-inhibitors-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyWed, 11 Feb 2026 04:05:00 +1300https://doi.org/10.2147/PTT.S565823https://www.dovepress.com/prevalence-of-genital-psoriasis-and-its-impact-on-patients-sexual-life-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyWed, 21 Jan 2026 00:00:00 +1300https://doi.org/10.2147/PTT.S516803https://www.dovepress.com/bidirectional-associations-between-substance-abuse-and-psoriasis-a-pro-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyWed, 07 Jan 2026 00:00:00 +1300https://doi.org/10.2147/PTT.S557781https://www.dovepress.com/successful-treatment-of-two-rare-pediatric-keratinization-disorders-wi-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyTue, 06 Jan 2026 00:00:00 +1300https://doi.org/10.2147/PTT.S553794https://www.dovepress.com/real-world-experience-of-guselkumab-in-the-elderly-population-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyFri, 26 Dec 2025 22:25:00 +1300https://doi.org/10.2147/PTT.S549502https://www.dovepress.com/global-trends-and-future-predictions-of-psoriasis-burden-insights-from-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyWed, 24 Dec 2025 02:55:00 +1300https://doi.org/10.2147/PTT.S558419https://www.dovepress.com/antibodies-targeting-gasdermin-e-as-a-potential-therapeutic-option-for-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyThu, 18 Dec 2025 02:45:00 +1300https://doi.org/10.2147/PTT.S567601https://www.dovepress.com/pegylated-peptide-for-targeted-inhibition-of-human-antigen-r-as-a-nove-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapySat, 29 Nov 2025 05:25:00 +1300https://doi.org/10.2147/PTT.S563589https://www.dovepress.com/neurofunctional-reversibility-in-psoriasis-vulgaris-after-il-17a-inhib-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyFri, 31 Oct 2025 05:00:00 +1300https://doi.org/10.2147/PTT.S554255https://www.dovepress.com/predictors-of-successful-secukinumab-dose-tapering-in-moderate-to-seve-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyFri, 17 Oct 2025 18:50:00 +1300https://doi.org/10.2147/PTT.S531447https://www.dovepress.com/evaluating-the-role-of-disease-duration-in-systemic-therapy-response-a-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyMon, 13 Oct 2025 18:15:00 +1300https://doi.org/10.2147/PTT.S544568https://www.dovepress.com/integrated-single-cell-rna-sequencing-and-proteome-wide-mendelian-rand-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyFri, 10 Oct 2025 21:15:00 +1300https://doi.org/10.2147/PTT.S535791https://www.dovepress.com/codon-usage-bias-and-genomic-architecture-of-79-psoriasis-susceptibili-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyThu, 25 Sep 2025 00:30:00 +1200https://doi.org/10.2147/PTT.S545695https://www.dovepress.com/vunakizumab-for-treatment-of-acrodermatitis-continua-of-hallopeau-a-ca-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyTue, 23 Sep 2025 19:40:00 +1200https://doi.org/10.2147/PTT.S552600https://www.dovepress.com/long-term-real-world-effectiveness-and-drug-survival-of-guselkumab-in--peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyTue, 16 Sep 2025 17:30:00 +1200https://doi.org/10.2147/PTT.S533005https://www.dovepress.com/epidemiology-of-hypertension-in-psoriasis-an-analysis-of-trends-from-2-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyWed, 27 Aug 2025 20:05:00 +1200https://doi.org/10.2147/PTT.S532112https://www.dovepress.com/machine-learning-driven-prediction-models-for-brodalumab-therapeutic-e-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyThu, 21 Aug 2025 05:10:00 +1200https://doi.org/10.2147/PTT.S531925https://www.dovepress.com/the-skin-brain-axis-in-psoriasis-and-depression-roles-of-inflammation--peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyMon, 18 Aug 2025 20:45:00 +1200https://doi.org/10.2147/PTT.S535900https://www.dovepress.com/biosimilars-for-the-treatment-of-moderate-to-severe-chronic-plaque-pso-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyMon, 18 Aug 2025 17:55:00 +1200https://doi.org/10.2147/PTT.S510156https://www.dovepress.com/causal-effect-of-plasma-fatty-acid-profiles-on-psoriasis-risk-genetic--peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapySat, 16 Aug 2025 02:30:00 +1200https://doi.org/10.2147/PTT.S538518https://www.dovepress.com/beyond-skin-clearance-personalized-strategies-for-dlqi-improvement-in--peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyWed, 13 Aug 2025 01:20:00 +1200https://doi.org/10.2147/PTT.S534881https://www.dovepress.com/tyk2-rs34536443-p1104a-variant-suppresses-icam1-mediated-inflammation--peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyTue, 12 Aug 2025 02:05:00 +1200https://doi.org/10.2147/PTT.S535434https://www.dovepress.com/bimekizumab-the-first-fda-approved-dual-il-17ail-17f-inhibitor-for-pla-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyTue, 05 Aug 2025 22:45:00 +1200https://doi.org/10.2147/PTT.S544166https://www.dovepress.com/utilization-and-costs-of-laboratory-monitoring-in-biological-and-non-b-peer-reviewed-fulltext-article-PTTPsoriasis: Targets and TherapyTue, 05 Aug 2025 10:35:00 +1200https://doi.org/10.2147/PTT.S531836